Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Miami, Florida Clinical Trials

A listing of Miami, Florida clinical trials actively recruiting patient volunteers.

RESULTS

Found (11) clinical trials

Examining the Distal Gut Microbiome After Spinal Cord Injury

The purpose of this research study is to learn more about the causes of gastrointestinal dysfunction after spinal cord injury. It has been thought that the microbiome (the community of bacteria in the body) may be one such cause. The study will examine whether changes in the distal gut microbiome ...

Phase N/A

0.64 miles

Learn More »

Interactive Telehealth for Pressure Ulcer Prevention After SCI

Overview and Rationale: Pressure ulcers (PUs) are a frequent and serious secondary complication after SCI with an annual incidence of 31% and a lifetime incidence of up to 85%. PUs are linked to increased morbidity and mortality. As medical or surgical repair of established PUs is difficult and costly, the ...

Phase N/A

0.64 miles

Learn More »

A Study to Evaluate the Efficacy Safety and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)

This study is designed to evaluate the efficacy, safety, and pharmacokinetics of UTTR1147A compared with vedolizumab and with placebo in the treatment of participants with moderate to severe UC. This study will consist of two parts, Part A and Part B. Part A will test the induction of clinical remission ...

Phase

0.64 miles

Learn More »

Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory Acute Lymphoblastic Leukemia

This is a phase I study of the addition of pevonedistat to induction chemotherapy for AYA patients (16-39 years of age) with relapsed/refractory ALL utilizing a traditional 3+3 design with dose expansion cohort of 6 patients. Starting dose level for pevonedistat is 15 mg/m2. If the number of dose-limiting toxicities ...

Phase

0.64 miles

Learn More »

A Phase 1 Single-Dose Study to Determine the Effect of ACH-0144471 on Subjects With HI Compared to Healthy Matches

The purpose of this study is to determine if ACH-0144471 has any effects on participants with HI compared to healthy matched participants as it relates to safety, tolerability and PK.

Phase

0.64 miles

Learn More »

Remote Wheelchair Skills Training Efficacy

The objective of the study is to evaluate the effectiveness of remote training to teach clinicians how to train others in wheelchair skills.

Phase N/A

0.64 miles

Learn More »

A Trial to Evaluate the Safety Efficacy and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type

This is a phase 3, 12-week, multicenter, randomized, double-blind, placebo-controlled, fixed-dose trial designed to assess the efficacy, safety, and tolerability of brexpiprazole compared with placebo. The trial consists of a 12-week double-blind treatment period with a 30 day follow-up. The trial population will include male and female subjects between 55 ...

Phase

4.64 miles

Learn More »

A Phase II Study of MABp1 in Patients With Moderate to Severe Atopic Dermatitis

Phase 2, Open label, dose escalation study of two dose cohorts of MABp1 in patients with moderate to severe atopic dermatitis. The study is multicenter, and will consist of two dose levels: MABp1 administered subcutaneously at a dose of 200 mg weekly (4 doses) and MABp1 administered subcutaneously at a ...

Phase

4.64 miles

Learn More »

A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)

This multicenter, randomized, double-blind study will evaluate the efficacy, safety, and pharmacokinetics of atezolizumab (MPDL3280A) administered with nab-paclitaxel compared with placebo in combination with nab-paclitaxel in participants with locally advanced or metastatic triple-negative breast cancer (TNBC) who have not received prior systemic therapy for metastatic breast cancer (mBC). The safety ...

Phase

4.88 miles

Learn More »

Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis

This is study is a placebo controlled study where subjects with moderate to severe atopic dermatitis will be randomized (1:1:1:1) to receive ASN002 at 40 mg, 60 mg, or 80 mg, or placebo once daily for 12 weeks. Eligible subjects will get the opportunity to enroll in the 24 month ...

Phase

5.38 miles

Learn More »